Perbedaan Brigit Biofarmaka Teknologi Tbk. dan Bank Pan Indonesia Tbk: Brigit Biofarmaka Teknologi Tbk. diperdagangkan di Rp254 (kapitalisasi pasar 172,82 M, volume 24 jam 592,2 rb), sedangkan Bank Pan Indonesia Tbk diperdagangkan di Rp920 (kapitalisasi pasar 21,57 T, volume 24 jam 4,98 jt). Perbedaan utamanya: Bank Pan Indonesia Tbk jauh lebih besar — sekitar 124,8× kapitalisasi pasar Brigit Biofarmaka Teknologi Tbk., dan Bank Pan Indonesia Tbk lebih aktif diperdagangkan (4,98 jt vs 592,2 rb). Mana yang lebih baik tergantung tujuan investasimu.
| OBAT | PNBN | |
|---|---|---|
Kapitalisasi Pasar | 172,82 M | 21,57 T |
Volume | 592,2 rb | 4,98 jt |
Lot | 5,92 rb | 49,78 rb |
Perputaran | 147,05 jt | 4,55 M |
Harga Rata-rata | 248,31 | 913,41 |
Nilai Transaksi | 147,05 jt | 4,55 M |
Harga Ekuilibrium Indikatif | 254 | 920 |
Volume Ekuilibrium Indikatif | 10 | 2,41 rb |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Selengkapnya di halaman OBAT →PT Bank Pan Indonesia Tbk (the Bank) was established based on Deed No. 85 dated August 17, 1971 of notary Juliaan Nimrod Siregar gelar Mangaradja, S.H. Panin (Pan Indonesia) Bank was established by the merger of three small private banks. It was one of the first banks to be granted a foreign exchange license in 1972.
Selengkapnya di halaman PNBN →